An Updated Approach and Understanding of Breast Implant–Associated Anaplastic Large Cell Lymphoma

Neha Mehta-Shah, Paola Ghione

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare subtype of T-cell non-Hodgkin lymphoma that is usually localized to the fluid and capsule surrounding a breast implant. There have only been,1,000 cases and 36 deaths reported to date and the average patient presents 7 to 10 years following initial breast implant placement. Most patients present with delayed seromas, a breast mass, capsular abnormalities, lymphadenopathy, or cutaneous masses. Unlike other forms of non-Hodgkin lymphoma, most cases are cured with surgery alone. The challenge of BIA-ALCL surrounds its rarity—in regard to both its diagnosis as well as the limited available data to guide therapy for more advanced cases. Careful pathology evaluation to analyze both the fluid surrounding the capsule and the capsule itself is critical. Studies to identify which patients are at greater risk of development of this rare entity are ongoing.

Original languageEnglish
Pages (from-to)309-315
Number of pages7
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume20
Issue number3
DOIs
StatePublished - Mar 2022

Fingerprint

Dive into the research topics of 'An Updated Approach and Understanding of Breast Implant–Associated Anaplastic Large Cell Lymphoma'. Together they form a unique fingerprint.

Cite this